このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Fresenius Medical Care 過去の業績
過去 基準チェック /06
Fresenius Medical Careの収益は年間平均-23%の割合で減少していますが、 Healthcare業界の収益は年間 減少しています。収益は年間0.9% 3.1%割合で 増加しています。 Fresenius Medical Careの自己資本利益率は4.7%であり、純利益率は2.5%です。
主要情報
-23.0%
収益成長率
-22.1%
EPS成長率
| Healthcare 業界の成長 | 15.7% |
| 収益成長率 | 3.1% |
| 株主資本利益率 | 4.7% |
| ネット・マージン | 2.5% |
| 次回の業績アップデート | 30 Jul 2024 |
最近の業績更新
Recent updates
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively
Jun 17
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
May 30Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?
Feb 03Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?
Jan 19Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Jan 04Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt
Dec 17Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think
Nov 08収支内訳
収支内訳
Fresenius Medical Care の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 19,474 | 484 | 3,190 | 224 |
| 31 Dec 23 | 19,454 | 499 | 3,196 | 232 |
| 30 Sep 23 | 19,463 | 450 | 3,156 | 228 |
| 30 Jun 23 | 19,622 | 596 | 3,180 | 236 |
| 31 Mar 23 | 19,554 | 602 | 3,163 | 235 |
| 31 Dec 22 | 19,398 | 673 | 3,170 | 229 |
| 30 Sep 22 | 19,048 | 763 | 3,104 | 234 |
| 30 Jun 22 | 18,393 | 806 | 3,018 | 225 |
| 31 Mar 22 | 17,957 | 878 | 3,091 | 222 |
| 31 Dec 21 | 17,619 | 969 | 2,773 | 221 |
| 30 Sep 21 | 17,372 | 918 | 3,011 | 205 |
| 30 Jun 21 | 17,344 | 998 | 2,986 | 198 |
| 31 Mar 21 | 17,581 | 1,131 | 2,868 | 197 |
| 31 Dec 20 | 17,859 | 1,164 | 2,966 | 194 |
| 30 Sep 20 | 18,039 | 1,330 | 2,991 | 190 |
| 30 Jun 20 | 18,044 | 1,309 | 3,016 | 187 |
| 31 Mar 20 | 17,832 | 1,212 | 3,099 | 185 |
| 31 Dec 19 | 17,477 | 1,200 | 2,944 | 168 |
| 30 Sep 19 | 17,196 | 1,282 | 2,967 | 138 |
| 30 Jun 19 | 16,835 | 1,234 | 2,978 | 122 |
| 31 Mar 19 | 16,704 | 1,974 | 2,898 | 111 |
| 31 Dec 18 | 16,547 | 1,982 | 2,857 | 114 |
| 30 Sep 18 | 16,676 | 1,951 | 3,126 | 131 |
| 30 Jun 18 | 16,954 | 1,975 | 3,185 | 133 |
| 31 Mar 18 | 17,211 | 1,250 | 3,374 | 130 |
| 31 Dec 17 | 17,784 | 1,280 | 3,640 | 111 |
| 30 Sep 17 | 17,771 | 1,249 | 3,417 | 134 |
| 30 Jun 17 | 17,647 | 1,244 | 3,407 | 145 |
| 31 Mar 17 | 17,201 | 1,239 | 3,262 | 144 |
| 31 Dec 16 | 16,570 | 1,144 | 3,133 | 147 |
| 30 Sep 16 | 16,101 | 1,063 | 3,047 | 143 |
| 30 Jun 16 | 15,841 | 998 | 3,027 | 136 |
| 31 Mar 16 | 15,402 | 933 | 2,961 | 130 |
| 31 Dec 15 | 15,455 | 955 | 2,895 | 128 |
| 30 Sep 15 | 15,345 | 939 | 2,919 | 118 |
| 30 Jun 15 | 15,246 | 948 | 2,839 | 114 |
| 31 Mar 15 | 15,428 | 977 | 2,816 | 115 |
| 31 Dec 14 | 13,329 | 864 | 2,434 | 101 |
| 30 Sep 14 | 12,413 | 839 | 2,242 | 97 |
| 30 Jun 14 | 11,112 | 775 | 1,999 | 91 |
| 31 Mar 14 | 10,882 | 791 | 1,962 | 91 |
| 31 Dec 13 | 10,816 | 806 | 1,937 | 91 |
| 30 Sep 13 | 10,881 | 752 | 1,966 | 91 |
| 30 Jun 13 | 11,135 | 781 | 1,996 | 90 |
質の高い収益: FMEには€314.9M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が31st March, 2024に影響を及ぼしています。
利益率の向上: FMEの現在の純利益率 (2.5%)は、昨年(3.1%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: FMEの収益は過去 5 年間で年間23%減少しました。
成長の加速: FMEは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: FMEは過去 1 年間で収益成長率がマイナス ( -19.7% ) となったため、 Healthcare業界平均 ( -2.2% ) と比較することが困難です。
株主資本利益率
高いROE: FMEの 自己資本利益率 ( 4.7% ) は 低い とみなされます。